These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20705004)

  • 1. Combinatorial chemoenzymatic strategies for in vitro glycorandomization: Efforts toward antibiotic optimization.
    Fu X; Langenhan JM; Thorson JS
    Discov Med; 2004 Apr; 4(21):111-4. PubMed ID: 20705004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic optimization via in vitro glycorandomization.
    Fu X; Albermann C; Jiang J; Liao J; Zhang C; Thorson JS
    Nat Biotechnol; 2003 Dec; 21(12):1467-9. PubMed ID: 14608364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoglycorandomization and chemoenzymatic glycorandomization: two complementary tools for natural product diversification.
    Langenhan JM; Griffith BR; Thorson JS
    J Nat Prod; 2005 Nov; 68(11):1696-711. PubMed ID: 16309329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Sweetening' natural products via glycorandomization.
    Griffith BR; Langenhan JM; Thorson JS
    Curr Opin Biotechnol; 2005 Dec; 16(6):622-30. PubMed ID: 16226456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycorandomization: A promising diversification strategy for the drug development.
    Goel B; Tripathi N; Mukherjee D; Jain SK
    Eur J Med Chem; 2021 Mar; 213():113156. PubMed ID: 33460832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomization.
    Yang J; Fu X; Liao J; Liu L; Thorson JS
    Chem Biol; 2005 Jun; 12(6):657-64. PubMed ID: 15975511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fermenting next generation glycosylated therapeutics.
    Chen X
    ACS Chem Biol; 2011 Jan; 6(1):14-7. PubMed ID: 21250649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features and applications of bacterial glycosyltransferases: current state and prospects.
    Luzhetskyy A; Bechthold A
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):945-52. PubMed ID: 18777021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic tools for engineering natural product glycosylation.
    Blanchard S; Thorson JS
    Curr Opin Chem Biol; 2006 Jun; 10(3):263-71. PubMed ID: 16675288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural product glycorandomization.
    Yang J; Hoffmeister D; Liu L; Fu X; Thorson JS
    Bioorg Med Chem; 2004 Apr; 12(7):1577-84. PubMed ID: 15112655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweet antibiotics - the role of glycosidic residues in antibiotic and antitumor activity and their randomization.
    Kren V; Rezanka T
    FEMS Microbiol Rev; 2008 Aug; 32(5):858-89. PubMed ID: 18647177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution.
    Williams GJ; Zhang C; Thorson JS
    Nat Chem Biol; 2007 Oct; 3(10):657-62. PubMed ID: 17828251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievements and impacts of glycosylation reactions involved in natural product biosynthesis in prokaryotes.
    Song MC; Kim E; Ban YH; Yoo YJ; Kim EJ; Park SR; Pandey RP; Sohng JK; Yoon YJ
    Appl Microbiol Biotechnol; 2013 Jul; 97(13):5691-704. PubMed ID: 23715852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural product drug discovery in the next millennium.
    Cragg GM; Newman DJ
    Pharm Biol; 2001; 39 Suppl 1():8-17. PubMed ID: 21554167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversifying vancomycin via chemoenzymatic strategies.
    Fu X; Albermann C; Zhang C; Thorson JS
    Org Lett; 2005 Apr; 7(8):1513-5. PubMed ID: 15816740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin analogues containing monosaccharides exhibit improved antibiotic activity: a combined one-pot enzymatic glycosylation and chemical diversification strategy.
    Thayer DA; Wong CH
    Chem Asian J; 2006 Sep; 1(3):445-52. PubMed ID: 17441081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatic synthesis of cryptophycin/arenastatin natural products.
    Beck ZQ; Aldrich CC; Magarvey NA; Georg GI; Sherman DH
    Biochemistry; 2005 Oct; 44(41):13457-66. PubMed ID: 16216069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the glycosylation of natural products in actinomycetes.
    Salas JA; Méndez C
    Trends Microbiol; 2007 May; 15(5):219-32. PubMed ID: 17412593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.